ORMDL3 and liver cancer: In the above studies, it was found that silencing ORMDL3 can inhibit the autophagy of liver cancer cells induced by sorafenib, and it is known that autophagy is closely related to oxidative stress, so, changes in the oxidative stress level of cells were detected after silencing ORMDL3.